I assumed that it would take time for Zimmer to capitalize on the synergenic nature of a merger with Amedica. I suspect however that Kyoceras new building and modifications combined with Zimmer modifying 3 of its manufacturing facilities in Warsaw, China, & Canada to meet fda compliance would allow it to ramp up quickly upon close of deal.
How likely would Kyocera be manufacturing right now to build up inventory on its dime?
News 
Market Data 
Discover 
AI
